白花丹醌透明质酸-癸烯基丁二酸酐新型纳米胶束的制备及体外释放研究  

Preparation and in Vitro Evaluation of a Novel Nanomicelle Containing HA-DSA Containing Alboflora Danquinone

作　　者：杨蓉[1] 杜彭飞 易静 舒婷 任静[1] YANG Rong;DU Pengfei;YI Jing;SHU Ting;REN Jing(College of Pharmacy,Chengdu University,Sichuan Pharmaceutical Preparation and Equipment Engineering Technology Research Center,Chengdu 610106,China)

机构地区：[1]成都大学药学院,四川省药物制剂及装备工程技术研究中心,成都610106

出　　处：《中国药学杂志》2025年第3期266-271,共6页Chinese Pharmaceutical Journal

基　　金：国家药监局药物制剂体内外相关性技术研究重点实验室开放课题资助(2022-KFKT-002)。

摘　　要：目的制备白花丹醌(plumbagin,PLB)透明质酸-癸烯基丁二酸酐(HA-DSA)新型纳米胶束,并对其质量及体外释药规律进行研究。方法首先合成载药材料HA-DSA,再以粒径为指标,用Box-Behnken响应面优化PLB-HA-DSA处方工艺,采用透析法评价PLB-HA-DSA的体外释放并拟合最优方程。结果PLB-HA-DSA最佳处方工艺为:有机相-水相(1∶20),药物与材料比为1∶11;PLB-HA-DSA呈球状分布,粒径为(110.71±2.03)nm,Zeta电位为(-42.12±2.34)mV,包封率为(92.12±0.06)%,载药量为(5.13±1.06)%;体外释放实验中,PLB-HA-DSA累积释放度较原料药明显减慢。结论本研究成功制备得到PLB-HA-DSA纳米胶束,可减缓PLB的体外释放,具有一定的缓释作用。OBJECTIVE To prepare a new type of hyaluronic acid-decenylsuccinic anhydride(HA-DSA)nanomicelles loaded with plumbagin(PLB),and to study their quality and in vitro drug release.METHODS Firstly,the drug-loaded material HA-DSA was synthesized,and then the formulation process of PLB-HA-DSA was optimized by Box-Behnken response surface and the in vitro release of PLB-HA-DSA was evaluated by dialysis method and the optimal equation was fitted.RESULTS The optimal formulation process of PLB-HA-DSA was as follows:organic phase-aqueous phase(1∶20),drug:material ratio(1∶11).PLB-HA-DSA was spherical with a particle size of(110.71±2.03)nm,a Zeta potential of(-42.12±2.34)mV,an encapsulation efficiency of(92.12±0.06)%,and a drug load of(5.68±0.06)%.In the in vitro release experiment,the cumulative release degree of PLB-HA-DSA was significantly lower than that of the API.CONCLUSION PLB-HA-DSA nanomicelles are successfully prepared,which could retard the release of PLB in vitro and have a certain sustained release effect.

关 键 词：白花丹醌 透明质酸-癸烯基丁二酸酐胶束 Box-Behnken响应面优化 体外释放 纳米胶束 

分 类 号：R944[医药卫生—药剂学]